antagonist ([5P7]CCL5), and a small-molecule inverse agonist (maraviroc) (Tan, Zhu et al. 2013, Zheng, Han its constitutive activity (Yen, Schafer et al. 2022) which is also supported by mutagenesis studies (Han

Today is also the first session of our hands-on workshop with Dr. Sam Hoare.

GPCR University hands-on workshop with Dr. 

Kong , Xu Wang , Ya-Kun Gao , Dan-Dan Zhang , Xiao-Fu Huang , Yu Song , Wen-Di Zhang , Rui-Juan Guo , Han Li , Mei Han Tags Breast cancer , Regulator of G protein signaling 5 , Vascular remodeling , Vascular

Hui-Juan Zhong , Shan-He Yu , Lu Jiang , Sheng-Yue Wang , Hai Fang , Rui-Hong Zhang , Yue Zhu , Hong-Mei

speakers: Alexei Sirbu (Max Delbrück Center); Polina Isaikina ( Paul Scherrer Institut PSI); Jianming Han Trejo (UCSD); Brian Arey (Bristol-Myers Squibb); Katarzyna Marcinkiewicz (Nature Communications); Naomi Handly